Pe'er J - Search Results

1

Clinical review: treatment of vitreoretinal lymphoma.

Pe'er J, Hochberg FH, Foster CS. Pe'er J, et al. Ocul Immunol Inflamm. 2009 Sep-Oct;17(5):299-306. doi: 10.3109/09273940903370755. Ocul Immunol Inflamm. 2009. PMID: 19831557 Review.

2

Maculopathy in patients with primary CNS lymphoma treated with chemotherapy in conjunction with blood-brain barrier disruption.

Vicuna-Kojchen J, Frenkel S, Siegal T, Shalom E, Chowers I, Pe'er J. Vicuna-Kojchen J, et al. Br J Ophthalmol. 2008 Feb;92(2):231-5. doi: 10.1136/bjo.2007.130062. Br J Ophthalmol. 2008. PMID: 18227203

3

Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.

Frenkel S, Hendler K, Siegal T, Shalom E, Pe'er J. Frenkel S, et al. Br J Ophthalmol. 2008 Mar;92(3):383-8. doi: 10.1136/bjo.2007.127928. Br J Ophthalmol. 2008. PMID: 18303160

4

Intraocular T-cell Lymphoma: Clinical Presentation, Diagnosis, Treatment, and Outcome.

Chaput F, Amer R, Baglivo E, Touitou V, Kozyreff A, Bron D, Bodaghi B, LeHoang P, Bergstrom C, Grossniklaus HE, Chan CC, Pe'er J, Caspers LE. Chaput F, et al. Ocul Immunol Inflamm. 2017 Oct;25(5):639-648. doi: 10.3109/09273948.2016.1139733. Epub 2016 Mar 22. Ocul Immunol Inflamm. 2017. PMID: 27002464

5

The importance of cytokines analysis in the diagnosis of vitreoretinal lymphoma.

Frenkel S, Pe'er J, Kaufman R, Maly B, Habot-Wilner Z. Frenkel S, et al. Acta Ophthalmol. 2020 Sep;98(6):e668-e673. doi: 10.1111/aos.14347. Epub 2020 Jan 29. Acta Ophthalmol. 2020. PMID: 31994839 Free article.

6

Efficacy and safety of intravitreal methotrexate for vitreo-retinal lymphoma - 20 years of experience.

Habot-Wilner Z, Frenkel S, Pe'er J. Habot-Wilner Z, et al. Among authors: pe er j. Br J Haematol. 2021 Jul;194(1):92-100. doi: 10.1111/bjh.17451. Epub 2021 Apr 26. Br J Haematol. 2021. PMID: 33900619

7

Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma.

Carbonell D, Mahajan S, Chee SP, Sobolewska B, Agrawal R, Bülow T, Gupta V, Jones NP, Accorinti M, Agarwal M, Batchelor T, Biswas J, Cimino L, tenDam-van Loon NH, de-la-Torre A, Frenkel S, Pe'er J, Kramer M, Miserocchi E, Mochizuki M, Ness T, Rosenbaum JT, Sen HN, Simion M (VRL patient), Sitter H, Vasconcelos-Santos DV, Habot-Wilner Z, Coupland SE, Pulido JS, Smith J, Thorne JE, Zierhut M; Study Group for Vitreoretinal Lymphoma Diagnostics. Carbonell D, et al. Among authors: pe er j. Ocul Immunol Inflamm. 2021 Apr 3;29(3):507-520. doi: 10.1080/09273948.2021.1878233. Epub 2021 May 19. Ocul Immunol Inflamm. 2021. PMID: 34009095

8

An experimental model for infiltration of malignant lymphoma to the eye and brain.

Assaf N, Hasson T, Hoch-Marchaim H, Pe'er J, Gnessin H, Deckert-Schlüter M, Wiestler OD, Hochman J. Assaf N, et al. Virchows Arch. 1997 Dec;431(6):459-67. doi: 10.1007/s004280050124. Virchows Arch. 1997. PMID: 9428935

9

Ocular and orbital complications following the treatment of retinoblastoma.

Anteby I, Ramu N, Gradstein L, Miskin H, Pe'er J, Benezra D. Anteby I, et al. Eur J Ophthalmol. 1998 Apr-Jun;8(2):106-11. doi: 10.1177/112067219800800210. Eur J Ophthalmol. 1998. PMID: 9673480

10

Entry routes of malignant lymphoma into the brain and eyes in a mouse model.

Hochman J, Assaf N, Deckert-Schlüter M, Wiestler OD, Pe'er J. Hochman J, et al. Cancer Res. 2001 Jul 1;61(13):5242-7. Cancer Res. 2001. PMID: 11431365

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

264 results

Search Page